AbCellera Biologics Inc. has grown revenue −23% a year over three years and −32% a year over five. Revenue growth, 3-year annual rate: −23% (Biotechnology median +17%). Revenue growth, 5-year rate: −32%, growth has picked up over the last three years. Years of annual history on file: 7, FY2019 to FY2025, as filed.

ABCLAbCellera Biologics Inc.

Healthcare

$12.55+178% 1Y

$12.55

$2.7852 weeks$14.83

Is it growing?

Good

Growing: revenue growing +101% year on year and operating margin widening (+373.2 points).

2 good, 1 without data

Revenue trend+101% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −32% a year.

Margin direction+373.2 points operating

Trailing-twelve-month operating margin, -789.3% now against -1162.5% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is ABCL growing?

AbCellera Biologics Inc. has grown revenue −23% a year over three years and −32% a year over five.

−23%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −32%
Revenue growth, 5-year rate · −23% over three · growth has picked up over the last three years
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›